According to Xeris Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -S$39.37 M. In 2023 the company made an earning of -S$48.06 M an increase over its 2022 earnings that were of -S$0.11 B.The earnings displayed on this page is the company's Pretax Income.